share_log

Insider Sale: Director at $CPRX (CPRX) Sells 72,500 Shares

Insider Sale: Director at $CPRX (CPRX) Sells 72,500 Shares

内部销售:$CPRX (CPRX) 的董事出售了72,500股
Quiver Quantitative ·  11/22 06:17

PATRICK J MCENANY, a director at $CPRX ($CPRX), sold 72,500 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares. Following this trade, they now own 4,478,169 shares of $CPRX stock.

董事PATRICK J MCENANY在2024年11月20日以每股$ CPRX($ CPRX)的价格出售了72500股公司股票。我们从最近的SEC备案中获得了交易数据。这是大约1.6%股份的出售。在这笔交易之后,他们现在拥有4478169股$ CPRX股票。

$CPRX Insider Trading Activity

$CPRX内部交易活动

$CPRX insiders have traded $CPRX stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

$CPRX内部人士在过去6个月中已经18次在公开市场上交易$ CPRX股票。在这些交易中,0次是购买,18次是销售。

Here's a breakdown of recent trading of $CPRX stock by insiders over the last 6 months:

以下是过去6个月$ CPRX股票内部人员最近的交易情况:

  • PATRICK J MCENANY has traded it 7 times. They made 0 purchases and 7 sales, selling 800,000 shares.
  • DAVID S TIERNEY sold 15,000 shares.
  • STEVE MILLER (Chief Op. & Scientific Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 150,000 shares.
  • GARY INGENITO (Chief Med. & Reg. Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 180,000 shares.
  • CARMEN JEFFREY DEL (Chief Commercial Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 43,599 shares.
  • RICHARD J DALY (President and CEO) sold 17,323 shares.
  • MOLLY HARPER sold 5,333 shares.
  • PATRICK J MCENANY已进行了7次交易。他们进行了0次购买和7次销售,出售了80万股。
  • DAVID S TIERNEY出售了15000股。
  • STEVE MILLER(首席运营和科学官员)已进行了3次交易。他们进行了0次购买和3次销售,出售了15万股。
  • GARY INGENITO(首席医药和注册官员)已进行了2次交易。他们进行了0次购买和2次销售,出售了18万股。
  • CARMEN JEFFREY DEL(首席商务官)已进行了3次交易。他们进行了0次购买和3次销售,共售出43,599股。
  • RICHARD J DALY(总裁兼首席执行官)卖出了17,323股。
  • MOLLY HARPER卖出了5,333股。

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

要跟踪内部交易,请查看Quiver Quantitative的内部交易特斯拉-仪表。

$CPRX Hedge Fund Activity

CPRX对冲基金交易活动

We have seen 158 institutional investors add shares of $CPRX stock to their portfolio, and 145 decrease their positions in their most recent quarter.

我们看到有158家机构投资者在他们最近的一个季度中增加了$CPRX股票的持股数量,而有145家减少了他们的持仓。

Here are some of the largest recent moves:

以下是一些最近最大的交易动态:

  • DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 2,897,671 shares (-31.7%) from their portfolio in Q3 2024
  • JANUS HENDERSON GROUP PLC removed 1,815,450 shares (-83.4%) from their portfolio in Q3 2024
  • MORGAN STANLEY added 810,595 shares (+80.0%) to their portfolio in Q3 2024
  • POINT72 ASSET MANAGEMENT, L.P. removed 618,296 shares (-100.0%) from their portfolio in Q3 2024
  • CITADEL ADVISORS LLC removed 557,683 shares (-95.7%) from their portfolio in Q3 2024
  • QUBE RESEARCH & TECHNOLOGIES LTD added 538,506 shares (+418.3%) to their portfolio in Q3 2024
  • OPALEYE MANAGEMENT INC. removed 527,500 shares (-82.4%) from their portfolio in Q3 2024
  • DEERFIELD MANAGEMENT COMPANY, L.P.(C系列)在2024年第三季度从其组合中减少了2,897,671股(-31.7%)。
  • JANUS HENDERSON GROUP PLC在2024年第三季度从其投资组合中减少了1,815,450股(-83.4%)
  • 摩根士丹利在2024年第三季度向其投资组合增加了810,595股(+80.0%)
  • POINT72资产管理有限合伙公司在2024年第三季度从其投资组合中减少了618,296股(-100.0%)
  • CITADEL ADVISORS LLC在2024年第三季度从其投资组合中减少了557,683股(-95.7%)
  • QUBE RESEARCH & TECHNOLOGIES LTD在2024年第三季度向其投资组合增加了538,506股(+418.3%)
  • OPALEYE管理公司在2024年第三季度从其投资组合中减少了527,500股(-82.4%)

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

要追踪对冲基金的股票组合,请查看Quiver Quantitative的机构持股仪表板。


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

本文不构成金融建议。有关Quiver Quantitative的免责声明,请查看更多信息。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发